Wenzhen Kang

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

Huijie Bian, Zhaohui Zheng, Zheng Zhang et al. · medRxiv · 2020 · 172 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

[Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region].

Na Yao, Suna Wang, Jianqi Lian et al. · PubMed · 2020 · 85 citations · Full text

Medicine, Infectious Diseases, Pathology +15

Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

Huijie Bian, Zhaohui Zheng, Aidong Wen et al. · Signal Transduction and Targeted Therapy · 2021 · 66 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo

Chun-Qiu Hao, Yu-Mei Xie, Meijuan Peng et al. · Clinical and Experimental Medicine · 2013 · 49 citations

Medicine, Cell Biology, Pathology +14

Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study

Jian Sun, Hong Ma, Qing Xie et al. · Journal of Hepatology · 2016 · 44 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13